Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Cutting Edge Paper from Dr. McFarland and Colleagues

<< Previous

Bullboard Posts

Next >>

Comment by made2laston Aug 15, 2023 8:47am

136 Views

Post# 35588570

RE:RE:New Cutting Edge Paper from Dr. McFarland and Colleagues

Hi all;

james700 wrote: Here's the question, will this advancement by Dr. McFarland be incorporated into the Theralase ACT division or will this be a separate business venture and compete with tld-1433.

The new tech described is ruthenium based and should fall under the many patents held by Theralase.

Thanks;

made2last

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario